Logo of TCD Capital, which leads to the homepage when clicked.

Founders & Management

Attila Borbáth, Pascal Doguet

In Portfolio

Since: September 2022
In Vehicle(s): Fund II


Life Sciences

Synergia Medical has validly patented and developed an animal proof of concept of a drastic improvement of a technology known and implanted to many humans: A device that stimulates the vagal nerve to prevent epilepsy crises. The quality of the technology, the very warm reception by independent neurosurgeons and their colleagues at the Scientific Advisory Board, the economics and governance set up around the transaction are some of the reasons this company has passed through our selection process.

Subscribe to our Newsletter

We seek to customise the content to the segments we serve.

These are both fund investors and the entrepreneurs with whom we have created alliances.

We are happy to keep in touch.

TCD Form Template Style